Immune system drives pregnancy complications after fetal surgery in mice

January 27, 2014 by Steve Tokar, University of California, San Francisco

(Medical Xpress)—As a fetal surgeon at UC San Francisco, Tippi MacKenzie, MD, has long known that conducting surgery on a fetus to correct a problems such as spina bifida often results in preterm labor and premature birth.

Now, MacKenzie and her UCSF colleagues have shown that, in mice at least, after are triggered by activation of the mother's T cells – the same T cells that cause the body to reject a donor organ after transplant surgery

"Here at UCSF, the birthplace of fetal surgery, preterm labor has been described as the 'Achilles' heel' of the field because it diminishes the benefit of the surgery itself," said MacKenzie, an associate professor of surgery and director of research at the UCSF Fetal Treatment Center. "However, specific treatments have not been developed because until now, the biological triggers responsible for preterm birth have been unknown."

If the same fetal rejection mechanism is occurring in humans, she said, "we have the ability to design specific medical treatments to prevent it – for example, by using medications that target some of the pathways involved in T cell-mediated rejection."

The study was published online on January 15, 2014, in the Journal of Immunology and will be printed in the February 15 issue.

Normally, pregnancy is a robust form of immune tolerance, in which the pregnant mother naturally tolerates a genetically foreign fetus, MacKenzie explained. "This is in contrast to an organ transplant, where you need to administer immunosuppressive drugs to prevent the body from rejecting a foreign graft. Our study supports the idea that fetal intervention breaks this tolerance by activating the mother's immune system, suggesting that the biology behind preterm labor is similar to transplant rejection."

In their study, MacKenzie and her team used a of fetal intervention to show that, after fetal surgery, maternal T cells gather in the uterus. "These are effector T cells, which are the main cells responsible for rejecting a transplanted organ," said MacKenzie. "In a shift from the normal balance in the uterus, they outnumber regulatory T cells, which are usually responsible for suppressing an immune response against the fetus."

The scientists next worked with genetically modified mice that had T cells designed to recognize and reject one specific foreign protein. They transferred those T cells into the circulation of pregnant mice whose fetuses expressed that protein because they had inherited the gene from their father. The scientists found that, in mice that had fetal surgery, the transferred T cells multiplied and migrated to the uterus.

"It's known that in a normal pregnancy T cells that recognize the fetus can circulate in the mother and live in harmony with the fetus," said first author Marta Wegorzewska, a graduate student in the MacKenzie lab. "But when you perform fetal surgery, they get activated and go to the uterus."

Although the activated T cells were an important clue, the researchers' next step was to prove that they had a harmful effect on pregnancy. They designed an experiment in which half of the pups carried by a pregnant mouse were genetically identical to their mother – as is common among experimental mice – and half were genetically different and expressed foreign proteins inherited from the father. They then injected more of the foreign protein into each fetus in the litter. After this fetal intervention, the scientists observed that there were significantly more deaths among the genetically different pups than among the genetically identical pups.

They then repeated the experiment on a group of mice without T cells and found no difference in the rate of death between the two types of pups.

"This experiment demonstrates that activation of the mother's T after fetal surgery can mediate the death of genetically foreign fetuses," concluded MacKenzie.

She cautioned that there is a significant difference between her experimental mouse model and human pregnancy: If a mouse pregnancy has complications after fetal surgery, the outcome is not but the death of the fetus. "That said, this mouse model is a wonderful tool to study the immune mechanisms of pregnancy complications after surgery," MacKenzie said.

The next step for her team, she said, "is to determine to what extent fetal interventions trigger the mother's immune response in humans, or if there is some other cause. Those studies are currently under way."

Explore further: Maternal liver grafts more tolerable for children with rare disease

More information: "Fetal Intervention Increases Maternal T Cell Awareness of the Foreign Conceptus and Can Lead to Immune-Mediated Fetal Demise." Marta Wegorzewska, Amar Nijagal, Charissa M. Wong, Tom Le, Ninnia Lescano, Qizhi Tang, and Tippi C. MacKenzie, J Immunol 1302403; published ahead of print January 10, 2014, DOI: 10.4049/jimmunol.1302403

Related Stories

Maternal liver grafts more tolerable for children with rare disease

January 3, 2012
Children with a rare, life-threatening disease that is the most common cause of neonatal liver failure – biliary atresia – better tolerate liver transplants from their mothers than from their fathers, according ...

Three types of fetal cells can migrate into maternal organs during pregnancy

June 6, 2012
A pregnant woman's blood stream contains not only her own cells, but a small number of her child's, as well, and some of them remain in her internal organs long after the baby is born. Understanding the origin and identity ...

Researchers identify cells involved in placenta development

November 27, 2013
(Medical Xpress)—Dr. Hanna Mikkola and researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified a specific type of cell and a related cell communication pathway that ...

Pregnancy generates maternal immune-suppressive cells that protect the fetus

September 26, 2012
A new study published online in the journal Nature suggests it might be possible to develop vaccines to prevent premature birth and other pregnancy complications. If so, such vaccines would be the first intended to stimulate ...

Biologists discover solution to problem limiting development of human stem cell therapies

January 2, 2014
Biologists at UC San Diego have discovered an effective strategy that could prevent the human immune system from rejecting the grafts derived from human embryonic stem cells, a major problem now limiting the development of ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.